-
1
-
-
84887254519
-
Primary sclerosing cholangitis
-
Hirschfield GM, Karlsen TH, Lindor KD, Adams DH: Primary sclerosing cholangitis. Lancet 2013, 382(9904):1587-1599.
-
(2013)
Lancet
, vol.382
, Issue.9904
, pp. 1587-1599
-
-
Hirschfield, G.M.1
Karlsen, T.H.2
Lindor, K.D.3
Adams, D.H.4
-
2
-
-
75449104123
-
Diagnosis and management of primary sclerosing cholangitis
-
Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ: Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010, 51(2):660-678.
-
(2010)
Hepatology
, vol.51
, Issue.2
, pp. 660-678
-
-
Chapman, R.1
Fevery, J.2
Kalloo, A.3
Nagorney, D.M.4
Boberg, K.M.5
Shneider, B.6
Gores, G.J.7
-
3
-
-
84883150093
-
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management
-
Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD: Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 2013, 145(3):521-536.
-
(2013)
Gastroenterology
, vol.145
, Issue.3
, pp. 521-536
-
-
Eaton, J.E.1
Talwalkar, J.A.2
Lazaridis, K.N.3
Gores, G.J.4
Lindor, K.D.5
-
4
-
-
84882846687
-
Update on primary sclerosing cholangitis
-
Karlsen TH, Boberg KM: Update on primary sclerosing cholangitis. J Hepatol 2013, 59(3):571-582.
-
(2013)
J Hepatol
, vol.59
, Issue.3
, pp. 571-582
-
-
Karlsen, T.H.1
Boberg, K.M.2
-
5
-
-
80055025463
-
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
-
Imam MH, Sinakos E, Gossard AA, Kowdley KV, Luketic VA, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, DeCook AC, Enders F, Lindor KD: High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Aliment Pharmacol Ther 2011, 34(10):1185-1192.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, Issue.10
, pp. 1185-1192
-
-
Imam, M.H.1
Sinakos, E.2
Gossard, A.A.3
Kowdley, K.V.4
Luketic, V.A.5
Edwyn Harrison, M.6
McCashland, T.7
Befeler, A.S.8
Harnois, D.9
Jorgensen, R.10
Petz, J.11
Keach, J.12
DeCook, A.C.13
Enders, F.14
Lindor, K.D.15
-
6
-
-
70349263453
-
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
-
Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F: High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009, 50(3):808-814.
-
(2009)
Hepatology
, vol.50
, Issue.3
, pp. 808-814
-
-
Lindor, K.D.1
Kowdley, K.V.2
Luketic, V.A.3
Harrison, M.E.4
McCashland, T.5
Befeler, A.S.6
Harnois, D.7
Jorgensen, R.8
Petz, J.9
Keach, J.10
Mooney, J.11
Sargeant, C.12
Braaten, J.13
Bernard, T.14
King, D.15
Miceli, E.16
Schmoll, J.17
Hoskin, T.18
Thapa, P.19
Enders, F.20
more..
-
7
-
-
0037382288
-
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
-
Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD: Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124(4):889-893.
-
(2003)
Gastroenterology
, vol.124
, Issue.4
, pp. 889-893
-
-
Pardi, D.S.1
Loftus, E.V.2
Kremers, W.K.3
Keach, J.4
Lindor, K.D.5
-
8
-
-
0026730984
-
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial
-
Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992, 16(3):707-714.
-
(1992)
Hepatology
, vol.16
, Issue.3
, pp. 707-714
-
-
Beuers, U.1
Spengler, U.2
Kruis, W.3
Aydemir, U.4
Wiebecke, B.5
Heldwein, W.6
Weinzierl, M.7
Pape, G.R.8
Sauerbruch, T.9
Paumgartner, G.10
-
9
-
-
84877280092
-
Evolving frequency and outcomes of liver transplantation based on etiology of liver disease
-
Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH: Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013, 95(5):755-760.
-
(2013)
Transplantation
, vol.95
, Issue.5
, pp. 755-760
-
-
Singal, A.K.1
Guturu, P.2
Hmoud, B.3
Kuo, Y.F.4
Salameh, H.5
Wiesner, R.H.6
-
10
-
-
84888303439
-
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
-
Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, van Nieuwkerk KM, Drenth JP, Witteman BJ, Tuynman HA, Naber AH, Kingma PJ, van Buuren HR, van Hoek B, Vleggaar FP, van Geloven N, Beuers U, Ponsioen CY: Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013, 58(6):2045-2055.
-
(2013)
Hepatology
, vol.58
, Issue.6
, pp. 2045-2055
-
-
Boonstra, K.1
Weersma, R.K.2
van Erpecum, K.J.3
Rauws, E.A.4
Spanier, B.W.5
Poen, A.C.6
van Nieuwkerk, K.M.7
Drenth, J.P.8
Witteman, B.J.9
Tuynman, H.A.10
Naber, A.H.11
Kingma, P.J.12
van Buuren, H.R.13
van Hoek, B.14
Vleggaar, F.P.15
van Geloven, N.16
Beuers, U.17
Ponsioen, C.Y.18
-
11
-
-
77249164222
-
Genome-wide association analysis in primary sclerosing cholangitis
-
Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismuller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P, Stiehl A, Vermeire S, Beuers U, Manns MP, Schrumpf E, et al: Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010, 138(3):1102-1111.
-
(2010)
Gastroenterology
, vol.138
, Issue.3
, pp. 1102-1111
-
-
Karlsen, T.H.1
Franke, A.2
Melum, E.3
Kaser, A.4
Hov, J.R.5
Balschun, T.6
Lie, B.A.7
Bergquist, A.8
Schramm, C.9
Weismuller, T.J.10
Gotthardt, D.11
Rust, C.12
Philipp, E.E.13
Fritz, T.14
Henckaerts, L.15
Weersma, R.K.16
Stokkers, P.17
Ponsioen, C.Y.18
Wijmenga, C.19
Sterneck, M.20
Nothnagel, M.21
Hampe, J.22
Teufel, A.23
Runz, H.24
Rosenstiel, P.25
Stiehl, A.26
Vermeire, S.27
Beuers, U.28
Manns, M.P.29
Schrumpf, E.30
more..
-
12
-
-
84883219528
-
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4
-
Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, Laerdahl JK, Shiryaev A, Gotthardt DN, Weismuller TJ, Schramm C, Wittig M, Bergquist A, Bjornsson E, Marschall HU, Vatn M, Teufel A, Rust C, Gieger C, Wichmann HE, Runz H, Sterneck M, Rupp C, Braun F, Weersma RK, Wijmenga C, Ponsioen CY, Mathew CG, Rutgeerts P, Vermeire S, et al: Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 2013, 58(3):1074-1083.
-
(2013)
Hepatology
, vol.58
, Issue.3
, pp. 1074-1083
-
-
Ellinghaus, D.1
Folseraas, T.2
Holm, K.3
Ellinghaus, E.4
Melum, E.5
Balschun, T.6
Laerdahl, J.K.7
Shiryaev, A.8
Gotthardt, D.N.9
Weismuller, T.J.10
Schramm, C.11
Wittig, M.12
Bergquist, A.13
Bjornsson, E.14
Marschall, H.U.15
Vatn, M.16
Teufel, A.17
Rust, C.18
Gieger, C.19
Wichmann, H.E.20
Runz, H.21
Sterneck, M.22
Rupp, C.23
Braun, F.24
Weersma, R.K.25
Wijmenga, C.26
Ponsioen, C.Y.27
Mathew, C.G.28
Rutgeerts, P.29
Vermeire, S.30
more..
-
13
-
-
84878725018
-
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
-
Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismuller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Muller T, Srivastava B, Dalekos G, Nothen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, et al: Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 2013, 45(6):670-675.
-
(2013)
Nat Genet
, vol.45
, Issue.6
, pp. 670-675
-
-
Liu, J.Z.1
Hov, J.R.2
Folseraas, T.3
Ellinghaus, E.4
Rushbrook, S.M.5
Doncheva, N.T.6
Andreassen, O.A.7
Weersma, R.K.8
Weismuller, T.J.9
Eksteen, B.10
Invernizzi, P.11
Hirschfield, G.M.12
Gotthardt, D.N.13
Pares, A.14
Ellinghaus, D.15
Shah, T.16
Juran, B.D.17
Milkiewicz, P.18
Rust, C.19
Schramm, C.20
Muller, T.21
Srivastava, B.22
Dalekos, G.23
Nothen, M.M.24
Herms, S.25
Winkelmann, J.26
Mitrovic, M.27
Braun, F.28
Ponsioen, C.Y.29
Croucher, P.J.30
more..
-
14
-
-
84901244524
-
Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis
-
Andersen IM, Tengesdal G, Lie BA, Boberg KM, Karlsen TH, Hov JR: Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol 2014, 12(6):1019-28.
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, Issue.6
, pp. 1019-1028
-
-
Andersen, I.M.1
Tengesdal, G.2
Lie, B.A.3
Boberg, K.M.4
Karlsen, T.H.5
Hov, J.R.6
-
15
-
-
84883229970
-
Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis
-
Katt J, Schwinge D, Schoknecht T, Quaas A, Sobottka I, Burandt E, Becker C, Neurath MF, Lohse AW, Herkel J, Schramm C: Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis. Hepatology 2013, 58(3):1084-1093.
-
(2013)
Hepatology
, vol.58
, Issue.3
, pp. 1084-1093
-
-
Katt, J.1
Schwinge, D.2
Schoknecht, T.3
Quaas, A.4
Sobottka, I.5
Burandt, E.6
Becker, C.7
Neurath, M.F.8
Lohse, A.W.9
Herkel, J.10
Schramm, C.11
-
16
-
-
54349125713
-
Etiopathogenesis of primary sclerosing cholangitis
-
Chapman R, Cullen S: Etiopathogenesis of primary sclerosing cholangitis. World J Gastroenterol 2008, 14(21):3350-3359.
-
(2008)
World J Gastroenterol
, vol.14
, Issue.21
, pp. 3350-3359
-
-
Chapman, R.1
Cullen, S.2
-
17
-
-
77349114492
-
Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment
-
Gotthardt DN, Rudolph G, Kloters-Plachky P, Kulaksiz H, Stiehl A: Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc 2010, 71(3):527-534.
-
(2010)
Gastrointest Endosc
, vol.71
, Issue.3
, pp. 527-534
-
-
Gotthardt, D.N.1
Rudolph, G.2
Kloters-Plachky, P.3
Kulaksiz, H.4
Stiehl, A.5
-
18
-
-
84870834720
-
Non-IBD immunological diseases are a risk factor for reduced survival in PSC
-
Rupp C, Mummelthei A, Sauer P, Weiss KH, Schirmacher P, Stiehl A, Stremmel W, Gotthardt DN: Non-IBD immunological diseases are a risk factor for reduced survival in PSC. Liver Int 2013, 33(1):86-93.
-
(2013)
Liver Int
, vol.33
, Issue.1
, pp. 86-93
-
-
Rupp, C.1
Mummelthei, A.2
Sauer, P.3
Weiss, K.H.4
Schirmacher, P.5
Stiehl, A.6
Stremmel, W.7
Gotthardt, D.N.8
-
19
-
-
77955716668
-
Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis
-
Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S, Strassburg CP, Manns MP, Suerbaum S, Wedemeyer J, Lankisch TO: Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010, 72(2):284-291.
-
(2010)
Gastrointest Endosc
, vol.72
, Issue.2
, pp. 284-291
-
-
Negm, A.A.1
Schott, A.2
Vonberg, R.P.3
Weismueller, T.J.4
Schneider, A.S.5
Kubicka, S.6
Strassburg, C.P.7
Manns, M.P.8
Suerbaum, S.9
Wedemeyer, J.10
Lankisch, T.O.11
-
20
-
-
67349123124
-
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
-
Rudolph G, Gotthardt D, Kloters-Plachky P, Kulaksiz H, Rost D, Stiehl A: Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 2009, 51(1):149-155.
-
(2009)
J Hepatol
, vol.51
, Issue.1
, pp. 149-155
-
-
Rudolph, G.1
Gotthardt, D.2
Kloters-Plachky, P.3
Kulaksiz, H.4
Rost, D.5
Stiehl, A.6
-
21
-
-
29344470338
-
The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis
-
Pohl J, Ring A, Stremmel W, Stiehl A: The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2006, 18(1):69-74.
-
(2006)
Eur J Gastroenterol Hepatol
, vol.18
, Issue.1
, pp. 69-74
-
-
Pohl, J.1
Ring, A.2
Stremmel, W.3
Stiehl, A.4
-
22
-
-
69049098025
-
Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study
-
Lenz P, Conrad B, Kucharzik T, Hilker E, Fegeler W, Ullerich H, Heinecke A, Domschke W, Domagk D: Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study. Gastrointest Endosc 2009, 70(3):480-487.
-
(2009)
Gastrointest Endosc
, vol.70
, Issue.3
, pp. 480-487
-
-
Lenz, P.1
Conrad, B.2
Kucharzik, T.3
Hilker, E.4
Fegeler, W.5
Ullerich, H.6
Heinecke, A.7
Domschke, W.8
Domagk, D.9
-
23
-
-
33750510712
-
Biliary tract candidiasis: diagnostic and therapeutic approaches in a case series
-
Domagk D, Fegeler W, Conrad B, Menzel J, Domschke W, Kucharzik T: Biliary tract candidiasis: diagnostic and therapeutic approaches in a case series. Am J Gastroenterol 2006, 101(11):2530-2536.
-
(2006)
Am J Gastroenterol
, vol.101
, Issue.11
, pp. 2530-2536
-
-
Domagk, D.1
Fegeler, W.2
Conrad, B.3
Menzel, J.4
Domschke, W.5
Kucharzik, T.6
-
24
-
-
24744458143
-
Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis
-
Bjornsson E, Cederborg A, Akvist A, Simren M, Stotzer PO, Bjarnason I: Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2005, 40(9):1090-1094.
-
(2005)
Scand J Gastroenterol
, vol.40
, Issue.9
, pp. 1090-1094
-
-
Bjornsson, E.1
Cederborg, A.2
Akvist, A.3
Simren, M.4
Stotzer, P.O.5
Bjarnason, I.6
-
25
-
-
84873159368
-
Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis
-
Barrie A, Mourabet ME, Weyant K, Clarke K, Gajendran M, Rivers C, Park SY, Hartman D, Saul M, Regueiro M, Yadav D, Binion DG: Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis. Dig Dis Sci 2013, 58(1):222-228.
-
(2013)
Dig Dis Sci
, vol.58
, Issue.1
, pp. 222-228
-
-
Barrie, A.1
Mourabet, M.E.2
Weyant, K.3
Clarke, K.4
Gajendran, M.5
Rivers, C.6
Park, S.Y.7
Hartman, D.8
Saul, M.9
Regueiro, M.10
Yadav, D.11
Binion, D.G.12
-
26
-
-
84858705541
-
Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease
-
O'Toole A, Alakkari A, Keegan D, Doherty G, Mulcahy H, O'Donoghue D: Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. Clin Gastroenterol Hepatol 2012, 10(4):439-441.
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, Issue.4
, pp. 439-441
-
-
O'Toole, A.1
Alakkari, A.2
Keegan, D.3
Doherty, G.4
Mulcahy, H.5
O'Donoghue, D.6
-
27
-
-
84874117027
-
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis-a pilot study
-
Tabibian JH, Weeding E, Jorgensen RA, Petz JL, Keach JC, Talwalkar JA, Lindor KD: Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis-a pilot study. Aliment Pharmacol Ther 2013, 37(6):604-612.
-
(2013)
Aliment Pharmacol Ther
, vol.37
, Issue.6
, pp. 604-612
-
-
Tabibian, J.H.1
Weeding, E.2
Jorgensen, R.A.3
Petz, J.L.4
Keach, J.C.5
Talwalkar, J.A.6
Lindor, K.D.7
-
28
-
-
84887423367
-
Role of the microbiota and antibiotics in primary sclerosing cholangitis
-
Tabibian JH, Talwalkar JA, Lindor KD: Role of the microbiota and antibiotics in primary sclerosing cholangitis. Biomed Res Int 2013, 2013:389537.
-
(2013)
Biomed Res Int
, vol.2013
-
-
Tabibian, J.H.1
Talwalkar, J.A.2
Lindor, K.D.3
-
29
-
-
84896397311
-
Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis
-
Rupp C, Friedrich K, Folseraas T, Wannhoff A, Bode KA, Weiss KH, Schirmacher P, Sauer P, Stremmel W, Gotthardt DN: Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis. Aliment Pharmacol Ther 2014, 39(8):873-882.
-
(2014)
Aliment Pharmacol Ther
, vol.39
, Issue.8
, pp. 873-882
-
-
Rupp, C.1
Friedrich, K.2
Folseraas, T.3
Wannhoff, A.4
Bode, K.A.5
Weiss, K.H.6
Schirmacher, P.7
Sauer, P.8
Stremmel, W.9
Gotthardt, D.N.10
-
30
-
-
84891371749
-
Persistent candidemia in neonatal care units: risk factors and clinical significance
-
Hammoud MS, Al-Taiar A, Fouad M, Raina A, Khan Z: Persistent candidemia in neonatal care units: risk factors and clinical significance. Int J Infect Dis 2013, 17(8):e624-628.
-
(2013)
Int J Infect Dis
, vol.17
, Issue.8
, pp. e624-e628
-
-
Hammoud, M.S.1
Al-Taiar, A.2
Fouad, M.3
Raina, A.4
Khan, Z.5
-
31
-
-
84886992866
-
Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation
-
Gotthardt DN, Weiss KH, Rupp C, Bode K, Eckerle I, Rudolph G, Bergemann J, Kloeters-Plachky P, Chahoud F, Buchler MW, Schemmer P, Stremmel W, Sauer P: Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation. Endoscopy 2013, 45(11):890-896.
-
(2013)
Endoscopy
, vol.45
, Issue.11
, pp. 890-896
-
-
Gotthardt, D.N.1
Weiss, K.H.2
Rupp, C.3
Bode, K.4
Eckerle, I.5
Rudolph, G.6
Bergemann, J.7
Kloeters-Plachky, P.8
Chahoud, F.9
Buchler, M.W.10
Schemmer, P.11
Stremmel, W.12
Sauer, P.13
-
32
-
-
0023835746
-
Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation
-
Wiesner RH, Hermans PE, Rakela J, Washington JA 2nd, Perkins JD, DiCecco S, Krom R: Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 1988, 45(3):570-574.
-
(1988)
Transplantation
, vol.45
, Issue.3
, pp. 570-574
-
-
Wiesner, R.H.1
Hermans, P.E.2
Rakela, J.3
Washington, J.A.4
Perkins, J.D.5
DiCecco, S.6
Krom, R.7
-
33
-
-
83755164266
-
Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors
-
Zirkel J, Klinker H, Kuhn A, Abele-Horn M, Tappe D, Turnwald D, Einsele H, Heinz WJ: Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. Med Mycol 2012, 50(1):50-55.
-
(2012)
Med Mycol
, vol.50
, Issue.1
, pp. 50-55
-
-
Zirkel, J.1
Klinker, H.2
Kuhn, A.3
Abele-Horn, M.4
Tappe, D.5
Turnwald, D.6
Einsele, H.7
Heinz, W.J.8
-
34
-
-
84885493147
-
Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
-
Nunes CZ, Marra AR, Edmond MB, da Silva VE, Pereira CA: Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection. BMC Infect Dis 2013, 13:486.
-
(2013)
BMC Infect Dis
, vol.13
, pp. 486
-
-
Nunes, C.Z.1
Marra, A.R.2
Edmond, M.B.3
da Silva, V.E.4
Pereira, C.A.5
-
35
-
-
0026079526
-
Impaired clearance and organ localization of Candida albicans in obstructive jaundice
-
discussion 907
-
Katz S, Merkel GJ, Folkening WJ, Rosenthal RS, Grosfeld JL: Impaired clearance and organ localization of Candida albicans in obstructive jaundice. J Pediatr Surg 1991, 26(8):904-906. discussion 907.
-
(1991)
J Pediatr Surg
, vol.26
, Issue.8
, pp. 904-906
-
-
Katz, S.1
Merkel, G.J.2
Folkening, W.J.3
Rosenthal, R.S.4
Grosfeld, J.L.5
-
36
-
-
79955082224
-
TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection
-
Fei M, Bhatia S, Oriss TB, Yarlagadda M, Khare A, Akira S, Saijo S, Iwakura Y, Fallert Junecko BA, Reinhart TA, Foreman O, Ray P, Kolls J, Ray A: TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc Natl Acad Sci U S A 2011, 108(13):5360-5365.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.13
, pp. 5360-5365
-
-
Fei, M.1
Bhatia, S.2
Oriss, T.B.3
Yarlagadda, M.4
Khare, A.5
Akira, S.6
Saijo, S.7
Iwakura, Y.8
Fallert Junecko, B.A.9
Reinhart, T.A.10
Foreman, O.11
Ray, P.12
Kolls, J.13
Ray, A.14
-
37
-
-
84878700149
-
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans
-
Smeekens SP, Ng A, Kumar V, Johnson MD, Plantinga TS, van Diemen C, Arts P, Verwiel ET, Gresnigt MS, Fransen K, van Sommeren S, Oosting M, Cheng SC, Joosten LA, Hoischen A, Kullberg BJ, Scott WK, Perfect JR, van der Meer JW, Wijmenga C, Netea MG, Xavier RJ: Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat Commun 2013, 4:1342.
-
(2013)
Nat Commun
, vol.4
, pp. 1342
-
-
Smeekens, S.P.1
Ng, A.2
Kumar, V.3
Johnson, M.D.4
Plantinga, T.S.5
van Diemen, C.6
Arts, P.7
Verwiel, E.T.8
Gresnigt, M.S.9
Fransen, K.10
van Sommeren, S.11
Oosting, M.12
Cheng, S.C.13
Joosten, L.A.14
Hoischen, A.15
Kullberg, B.J.16
Scott, W.K.17
Perfect, J.R.18
van der Meer, J.W.19
Wijmenga, C.20
Netea, M.G.21
Xavier, R.J.22
more..
|